In a critical public health alert, the Telangana Drugs Control Administration (DCA) has ordered an immediate halt to the use of a popular children's medicine, Almont-Kid Syrup. The drastic action follows a laboratory report confirming the syrup is adulterated with the highly toxic substance Ethylene Glycol (EG).
Urgent Alert from Central Regulators
The state drug regulator's move was triggered by a direct alert from the Central Drugs Standard Control Organisation (CDSCO), East Zone, Kolkata. The central body's laboratory analysis of the syrup, identified as Levocetirizine Dihydrochloride and Montelukast Sodium Syrup, declared it as adulterated. The DCA's notification, issued on Saturday, January 10, 2026, strongly advises the public to cease using the syrup without delay.
Specific Batch and Manufacturer Identified
The advisory specifies the contaminated batch as Batch No.: AL-24002. This batch of Almont-Kid Syrup was manufactured by Tridus Remedies, based in Bihar. The syrup is commonly prescribed to treat conditions like allergies, hay fever, and asthma in children, making the contamination a severe concern for young patients.
"In light of the above, the public is hereby strongly advised to immediately stop the use of the above syrup, if in possession, and report the same to the nearest Drugs Control Authority without delay," stated the official DCA notification.
Public Action and Reporting Channels
The Telangana DCA has urged anyone who has the said product in their possession to not only stop its use but also to report it immediately. Citizens can contact the nearest Drugs Control Authority office. Additionally, the administration has provided a direct reporting channel.
The public may also report possession of the said product directly to the Drugs Control Administration, Telangana, through their Toll-Free Number.
This incident highlights ongoing concerns about drug safety and regulatory oversight in the pharmaceutical supply chain, especially for pediatric medications. Authorities are likely to intensify scrutiny on the manufacturer and the specific batch's distribution network.
